Lionheart Health Appoints Neurosurgery Pioneer Dr. Joseph C. Maroon to Advisory Board

By BioHacker Team
Lionheart Health, Inc. announced that renowned neurosurgeon and longevity-focused brain health authority Joseph C. Maroon, MD, FACS—Clinical Professor of Neurosurgery at UPMC and longtime Team Neurosurgeon for the Pittsburgh Steelers—has joined the company’s Scientific and Clinical Advisory Board.

TL;DR

Lionheart Health gains a strategic edge by adding renowned neurosurgeon Dr. Joseph Maroon to its advisory board, enhancing credibility for its brain health and longevity technologies.

Dr. Maroon will advise Lionheart Health on clinical study design and protocol translation for bioelectric therapies targeting neuroplasticity, inflammation reduction, and regenerative protein expression.

This collaboration aims to advance therapies that improve cognition and reduce neuroinflammation, potentially extending meaningful healthspan and enhancing quality of life during aging.

The Pittsburgh Steelers' team neurosurgeon, an expert in concussion management and longevity science, is now guiding bioelectric stimulation technology for brain health.

Found this article helpful?

Share it with your network and spread the knowledge!

Lionheart Health Appoints Neurosurgery Pioneer Dr. Joseph C. Maroon to Advisory Board

Lionheart Health, Inc. announced that Dr. Joseph C. Maroon has joined its Scientific and Clinical Advisory Board, bringing decades of neurosurgery expertise to the company's bioelectric regenerative medicine initiatives. Dr. Maroon, a board-certified neurosurgeon and Clinical Professor of Neurosurgery at the University of Pittsburgh Medical Center, will advise on brain health clinical study design, neurocognitive endpoint validation, and applications for concussion and neuroinflammation management. His appointment strengthens the company's focus on developing evidence-based bioelectric stimulation therapies designed to improve cognition, memory, and mood while supporting neuroplasticity.

The company's technologies align with Dr. Maroon's focus on neuroprotection and performance longevity, particularly through platforms like BodStim™ and Brain Band™. Lionheart Health is currently advancing multiple clinical initiatives focused on improving functional biomarkers of aging, including grip strength, gait speed, cognition, and inflammatory markers. Dr. Maroon's role will include translating regenerative signaling science into clinical protocols, with the neurosurgeon commenting that "optimizing brain health is central to extending meaningful healthspan." The company's intellectual property portfolio includes patents targeting key regenerative and neuroprotective signaling pathways such as Klotho, Brain-Derived Neurotrophic Factor (BDNF), and GDF10, which play critical roles in neuroplasticity and inflammation modulation.

Brain health represents one of three core pillars in which Lionheart Health is competing in the $101M XPRIZE Healthspan Competition. The company's Brain Band™ recently received a UCI Capstone Grant to advance device optimization, and Lionheart Health has been recognized as 2025 Micro Stimulator Developer of the Year by Medtech Outlook Magazine. The company has completed pre-clinical studies at AccuLab Life Sciences in San Diego and a pilot clinical study in Brazil, and is preparing to enroll participants in a combination BodStim™ and Brain Band™ clinical trial for brain health.

Dr. Maroon brings more than four decades of experience in academic neurosurgery, having performed thousands of complex brain and spine procedures while advancing minimally invasive techniques. He has served as Team Neurosurgeon for the Pittsburgh Steelers for decades and is a prolific scientific author with over 300 peer-reviewed publications. His research has contributed to understanding neuroinflammation, omega-3 fatty acids in brain protection, and integrative strategies for preserving cognitive function. Lionheart Health operates licensed longevity and wellness clinics and collaborates with academic institutions to generate peer-reviewed data supporting its therapies designed to activate regenerative signaling pathways to improve muscle strength, cognitive function, metabolic health, and immune resilience.

Curated from Newsworthy.ai

blockchain registration record for this content
BioHacker Team

BioHacker Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.